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Abstract 
Smoking cigarettes is the leading cause of preventable death in the United States. Menthol is 
well known to exacerbate tobacco addiction. It is unclear, however, if menthol directly effects 
dopamine release which may increase the reward associated with smoking or if menthol has any 
effect on environmental cues which act as reinforcers for smoking behavior. Study 1 used fast 
scan cyclic voltammetry to examine the effects of nicotine and menthol, administered alone and 
in combination, on phasic dopamine release in the nucleus accumbens of male Sprague-Dawley 
rats. Results confirmed that nicotine, but not menthol, enhances phasic dopamine release in the 
nucleus accumbens. Menthol added to nicotine did not enhance phasic dopamine release above 
that elicited by nicotine alone. Study 2 used an online survey to examine the relationship 
between menthol status and environmental cues on nicotine consumption in human smokers. 
Results determined that there is no significant relationship between menthol status and smoking 
behavior. Taken together these results suggest that nicotine is the driving force behind tobacco 
addiction and menthol may act as a facilitator to make nicotine consumption more appealing. 
 
Keywords: addiction, environmental cues, menthol, nicotine   
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Smoking Behavior: An Analysis of Menthol's Effect on Nicotine 
 Smoking tobacco cigarettes is the leading cause of preventable death in the United States 
(Biswas et al., 2016). Nicotine is the primary psychoactive and addictive component in tobacco 
cigarettes and is a powerful reinforcer in both animals and humans (Ahijevych & Garrett, 2010; 
Wickham, 2015).  Mentholated cigarettes have been shown to have greater addictive potential 
and are correlated with a lower quit rate than that associated with nonmenthol cigarettes (Fait et 
al., 2017; Henderson et al., 2017; Wickham, 2019). 
Nicotine  
Nicotine is inherently rewarding and has positive reinforcing effects which increase the 
probability of self-administration in animals, as well as negative reinforcing effects that relieve 
negative symptoms associated with withdrawal (Ikemoto & Bonci, 2014; Valentine & Sofuoglu, 
2018). Nicotine is a nicotinic acetylcholine receptor (nAChR) agonist that binds to nAChRs, 
facilitating the release of dopamine (DA) from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAc) (Benowitz, 2009; Ikemoto & Bonci, 2014). nAChRs are comprised of five 
subunits with the most abundant receptor subtypes in the mammalian brain being α4β2, α3β4, 
and α7 (Benowitz, 2009). The rapidly desensitizing α4β2 and α6β2, and slowly desensitizing 
α4α6β2 and α7 nAChR subtypes are believed to be the main mediating receptors in nicotine 
dependence (Benowitz, 2009; Picciotto et al., 2008).  
Smoking is the fastest route of administration, when a drug is inhaled it enters circulation 
rapidly and reaches the brain within seconds (Benowitz, 2009). Increased rates of absorption and 
drug entry into the brain are correlated with a greater “rush” and consequently the drug is more 
reinforcing (Benowitz, 2009). Nicotine is metabolized into cotinine in the liver by the enzyme 
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CYP2A6, cotinine has a longer half-life than nicotine and both are used as quantitative markers 
for nicotine exposure (Benowitz, 2009). 
Menthol 
Menthol is a naturally occurring cyclic monoterpene alcohol that has a pleasant mint 
flavor and creates a cooling sensation via transient receptor potential melanostatin 8 (TRPM8) 
receptors which masks the aversive taste of nicotine and provides relief from the irritation 
associated with inhaling tobacco smoke (Hans et al., 2012; Kamatou et al., 2013; Lehr et al., 
2021; Wickham, 2019). Menthol has two potential stereoisomers depending on the method of 
production, (-)-menthol and (+)-menthol, however, (-)-menthol appears to be more relevant for 
nicotine abuse because chronic exposure to (-)-menthol upregulates nAChR expression and 
increases DA neuron excitability whereas (+)-menthol exhibits no such effect (Henderson et al., 
2019). With this in mind, a recent study comparing these stereoisomers of menthol found that (-) 
-menthol and (+)-menthol may both effectively contribute to menthol-dependent exacerbation of 
tobacco dependence (Lehr et al., 2021).  
Menthol is a common flavorant in chewing gum and oral care products, and has been an 
additive in cigarettes since the 1920s (Ahijevych & Garrett, 2010; Anderson, 2011; Kamatou et 
al., 2013). Even cigarettes that are not labeled as menthols contain small amounts of menthol (Ai 
et al., 2016; Anderson, 2011; DeVito et al., 2016; Fait et al., 2017; Kamatou et al., 2013; Lee & 
Glantz, 2011). Cigarettes marketed as mentholated products contain a range between 2.9 – 19.6 
mg menthol/cigarette, while cigarettes marketed as nonmentholated products contain 1.8 – 73.5 
µg menthol/cigarette (Ai et al., 2016; Harrison et al., 2017). 
Nicotine and Menthol Interactions  
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Menthol exposure increases nicotine self-administration and produces a leftward shift of 
the inverted-U of nicotine’s dose response curve, this facilitating effect of menthol on nicotine 
self-administration is dose dependent (Biswas et al., 2016). Menthol also widens the dose-
response curve for nicotine’s euphoric and addictive effects, indicating nicotine is the driving 
force behind addictive behaviors and menthol can act as a motivator for continued nicotine use 
(Wickham, 2019). Menthol sustains and reinstates nicotine seeking behavior in rats, independent 
of TRPM8 receptor activity (Biswas et al., 2016; Harrison et al., 2017). This suggests that 
menthol, labeled or unlabeled, in most tobacco products could potentially contribute to the high 
rates of continued use of and relapse to tobacco, though acute exposure to menthol has not been 
shown to alter nicotine sensitivity (Valentine et al., 2018). Menthol also enhances the rewarding 
effect of nicotine and may directly facilitate nicotine consumption (Biswas et al., 2016; 
Wickham, 2019).  
Conversely, long term menthol treatment before nicotine exposure decreases nicotine 
reward-related behavior and the interactions between nicotine and menthol reduce nicotine’s 
reinforcing and positive subjective effects (Henderson et al., 2016; Valentine et al., 2018). 
Extended exposure to nicotine before exposure to menthol may elicit different interactions 
between nicotine and menthol because acquisition did not occur simultaneously. This could 
explain why Nesil and colleagues (2019) found that menthol decreased nicotine reward in their 
study involving rats that were trained to lever press for nicotine alone before they were separated 
into test groups, some of which received no nicotine during testing. This indicates that nicotine 
and menthol may have different effects when present in the blood stream individually compared 
to the effects that are present when combined. 
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Nicotine menthol interactions indicate that reduced concentrations of nicotine in 
cigarettes increases smoking cessation more in nonmenthol smokers than menthol smokers, and 
menthol smokers experience stronger cravings than nonmentholated smokers (Denlinger-Apte et 
al., 2019; Fait et al., 2017). Menthol smokers also have a reduced likelihood of successful 
smoking cessation, and relapse rate is more common with female African American menthol 
smokers (Smith et al., 2014). 
Sensory Effects 
Menthol cigarettes have a characteristic cool minty taste which can make them more 
appealing than nonmentholated cigarettes (Ahijevych & Garrett, 2010). This may enable menthol 
to facilitate smoking initiation by providing positive early smoking experiences and the minty 
taste of menthol may contribute as a reinforcer for smoking behavior (Ahijevych & Garrett, 
2010).  
Menthol can have an analgesic effect whereby it alleviates the irritation in the throat and 
lungs of first-time smokers, this can lead someone who was merely experimenting with smoking 
to develop a habit because they do not experience the negative side effects commonly associated 
with nonmentholated cigarettes (Anderson, 2011; Fait et al, 2017; Lehr et al., 2021). Smoke 
intake in established smokers may be affected by cigarette mentholation, specifically menthol 
smokers appear to have higher levels of smoke inhalation than nonmenthol smokers, and 
menthol also decreases oral nicotine aversion in mice and is correlated with taste and flavor 
association in human smokers (Fan et al, 2016; Strasser et al., 2013; Watson et al., 2017). 
The amount of menthol necessary to begin having slight sensory effects is 0.6 – 1.5 mg 
menthol/cigarette (Ai et al., 2016). Menthol masks the negative short-term physiological effects 
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of smoking including throat pain, burning, and cough which provides superficial relief to 
smokers; however, menthol does not reduce the stinging sensation produced by nicotine in the 
nose (Anderson, 2011; Renner et al., 2012). Menthol dramatically enhances pharmacological 
effects of nicotine including decrease in body temperature and analgesia and can act as a 
counterirritant directly at nAChRs (Alsharari et al., 2015; Hans et al., 2012). 
Systemic Effects 
Menthol smokers have poorer smoking outcomes, as well as higher expression of 
nAChRs in the VTA and other reward-related areas than nonmenthol smokers (Brody et al., 
2013; Wickham, 2015). Thus, menthol may influence neural responses to nicotine and may play 
a role in the poorer cessation outcomes menthol smokers experience. Chronic exposure of 
nicotine and menthol in combination significantly promotes α4β2 nAChR expression in the 
hippocampus, striatum, and prefrontal cortex of mice, and chronic exposure to menthol alone 
causes upregulation of these nAChR subtypes in the same brain regions (Alsharari et al., 2015). 
Chronic nicotine exposure results in increased amounts of nAChRs with a higher affinity for 
nicotine which leads to changes in reward-related DA release (Henderson et al., 2016). Acute 
menthol exposure, however, has no effect on nAChR function (Henderson et al., 2016). 
Chronic menthol exposure stabilizes lower sensitivity nAChRs and produces 
upregulation of midbrain α4* nAChRs on VTA DA neurons which may partially negate 
nicotine’s increased phasic DA release (Henderson et al., 2016). Menthol and nicotine in 
combination produce a significant increase of α4α6β2 nAChRs in the midbrain which is 
correlated with increased frequency of DA-neuron firing and enhancement of reward related 
behavior (Henderson et al., 2017). When paired with nicotine, menthol attenuates α3β4 nAChRs 
in humans through augmented desensitization which has important implications for menthols’ 
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analgesic effects in sensory nerves and may blunt or delay symptoms of nicotine withdrawal 
(Ton et al., 2015). 
Menthol is associated with increased nicotine to cotinine metabolic conversion and 
inhibits nicotine absorption which could lead to subsequent higher consumption of mentholated 
cigarettes to achieve the same level of nicotine exposure (Abobo et al., 2011). Menthol smokers 
also have slower nicotine clearance than nonmenthol smokers which suggests an overall greater 
exposure to nicotine per cigarette (DeVito et al., 2016). Menthol has an inhibitory effect on 
nicotine metabolism which is associated with lower urges to smoke and less severe withdrawal 
symptoms because nicotine remains unmetabolized in the blood stream and can interact with 
more nAChRs which results in greater desensitization and more DA release (Benowitz et al., 
2009; Valentine et al., 2018).  
This inhibition of nicotine metabolism could be a possible explanation for the decreased 
nicotine infusion seeking seen in preclinical studies. Menthol exposed subjects may have less of 
an incentive to receive more nicotine infusions since there is a greater amount of nicotine in their 
blood stream compared to nonmenthol exposed subjects that would require more nicotine 
infusions to attain an equivalent amount of nicotine in the blood stream. When undergoing 
forced abstinence, menthol smokers also experience less alleviation of short-term abstinence-
induced craving than nonmenthol smokers when given intravenous injections of nicotine 
(DeVito et al., 2016). 
Dopamine Release and Nicotine Induced Reward 
The mesolimbic DA system, extending from the VTA to the NAc, influences goal 
directed behaviors, and nicotine augments preexisting goal directed behaviors (Grimm et al., 
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2012; Wickham et al., 2014). DA release results in a pleasurable feeling and is vital to the 
reinforcing effects of drugs of abuse including nicotine (Benowitz, 2009; Grieder et al., 2019). 
During tonic, baseline, firing, very little DA is released, however, phasic firing, where high rates 
of neuron firing occur, there is increased DA release which is typically caused by the activation 
of excitatory inputs to DA neurons (Picciotto et al., 2008). 
Acute nicotine exposure elevates DA release in the NAc and hippocampus (Grimm et al., 
2012). Chronic use of nicotine and menthol in combination significantly increases DA levels in 
the NAc and produces greater reward-related behavior compared to nicotine alone (Henderson et 
al., 2017; Wickham, 2019; Zhang et al., 2018). 
In the aftermath of long-term exposure to nicotine, α4* nAChRs, and sometimes α6* 
nAChRs, upregulate and exhibit an increased sensitivity to nicotine (Akers et al., 2020). nAChRs 
on GABA neurons are rapidly desensitized due to their increased sensitivity to nicotine and this 
desensitization results in the disinhibition of VTA DA neurons and subsequently there is an 
increase in DA neurotransmission within the mesolimbic pathway (Akers et al., 2020). 
Excitatory inputs from medial VTA glutamate neurons, where α7 nAChRs are located, are also 
enhanced, and the combined changes in the inhibitory and excitatory transmission contributes to 
nicotine induced reward (Akers et al., 2020; Picciotto et al., 2008). β2* nAChRs in the VTA are 
necessary for GABA and dopaminergic signaling for reward and aversion respectively (Grieder 
et al., 2019) (see Figure 1). 
Figure 1 
Baseline Firing of Nicotinic Acetylcholine Receptors 
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Note. Figure 1a shows DA firing before nAChR desensitization. The DA neuron receives 
excitatory input from β2* receptor activation on the DA neuron itself, as well as α7 receptor 
activation on glutamate neurons, and the DA neuron receives inhibitory input from β2* receptor 
activation on GABA neurons. Tonic and phasic firing both occur before nAChR desensitization. 
(Picciotto et al., 2008) 
Firing of Nicotine Acetylcholine Receptors after Extended Nicotine Exposure 
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Note. Figure 1b shows DA firing after extended exposure to nicotine. β2* nAChRs are 
desensitized so there is no longer excitatory input from β2* receptor activation on the DA neuron 
itself and there is no longer inhibitory input from β2* receptor activation on the GABA neuron. 
DA release is still sustained due to the continued activation of excitatory input from α7 receptor 
activation on glutamate neurons since α7 nAChRs desensitize much slower than β2* nAChRs. 
(Picciotto et al., 2008). 
Environmental Cues 
Environmental cues are external stimuli associated with a certain behavior, such as drug 
use (Perry et al., 2014). Drug associated cues are important contributors to the effects of the 
associated drug and can also evoke drug seeking in times of abstinence (Palmatier & Bevins, 
2008). These cues also increase DA release in the NAc and are acquired through conditioned 
reinforcement (Perry et al., 2014; Wickham et al., 2013). Desensitization of nAChRs may 
enhance responses to and increase the salience of environmental cues that are paired with 
smoking (Brunzell & Picciotto, 2009). Cues that predict the administration of a reward evoke an 
increase in phasic DA firing to a greater degree than the expected rewards themselves (Day et al., 
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2010). Higher phasic:tonic DA firing ratios, such as those present when nicotine is in the brain, 
make cues more salient and easier to associate with smoking (Picciotto et al., 2008).  
Cues can produce withdrawal symptoms independent of their associated drug in both 
humans and animals (Perry et al, 2014). Contextual cues are environmental stimuli that are not 
directly related to the drug taking behavior, but are present in the background of drug taking 
activities and are therefore important mediators of drug-seeking behavior because the 
environment has become associated with drug taking (Perry et al., 2014). 
Smokers who experience simultaneous cues such as being in a smoking environment and 
seeing cigarettes burning in an ashtray experience cue-induced craving and increased smoking 
behavior (Conklin et al., 2019). Conditioned reinforcers such as flavorants, notably menthol, can 
act as orosensory cues which are important for the self-administration of tobacco products in 
humans (Palmatier et al., 2020; Wang et al., 2014; Wickham, 2019). Menthol can have an 
occasion setting effect wherein the presence of menthol can act as a cue for nicotine self-
administration, independent of TRPM8 receptor activity (Harrison et al., 2017). 
Smoking Demographics 
Sex and age dependent factors may underlie the influence of menthol on nicotine intake. 
Fait and colleagues (2017) found that adult male mice significantly increased nicotine intake 
when it was paired with menthol, whereas adult female mice did not show this preference. The 
adult male mice in this study also exhibited decreased locomotion whereas this behavioral 
response to menthol was not observed in any of the adolescent mice. Ross and colleagues (2016) 
found that, in human smokers, puff characteristics of individual cigarettes are indicative of daily 
nicotine intake and factors including sex and menthol status were significant predictors of daily 
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nicotine exposure. African Americans, females, lower socioeconomic status individuals, and 
adolescents are more likely to use mentholated cigarettes (Ahijevych & Garrett, 2010; Foulds et 
al., 2010; Ross et al., 2016; Wickham, 2015; Wickham, 2019). Among menthol smokers, young 
adults and members of the LGBTQIA+ community are less likely to have an intention to quit 
smoking (Smiley, 2018). 
Marketing for menthol cigarettes has historically targeted African Americans, women, 
and young populations (Lee & Glantz, 2011; Smith et al., 2020; Wickham, 2019). Younger 
populations may be drawn to menthol cigarettes and this may result in menthol cigarettes acting 
as a “starter product” which can lead to the development of a smoking habit (Ahijevych & 
Garrett, 2010; Lee & Glantz, 2011). Menthol smokers who are young and in a racial or ethnic 
minority have a lower quit rate than nonmenthol smokers (Ahijevych & Garrett, 2010; Foulds et 
al., 2010). 
The Present Studies 
The purpose of Study 1 was to examine if menthol alone alters phasic DA release given 
that menthol can influence nicotine receptor expression. Furthermore, this study examined 
whether menthol could influence nicotine’s ability to drive DA release. The first hypothesis was 
that nicotine alone would significantly increase DA release relative to baseline, given that 
previous studies have shown similar results (Picciotto et al., 2008). The second hypothesis was 
that menthol alone would not increase DA levels relative to baseline given that acute menthol 
has no effect on nAChR function (Henderson et al., 2016). And the third hypothesis was that 
when combined with nicotine menthol would have an additive effect on DA release in the NAc 
relative to baseline, given that menthol increases nicotine self-administration in preclinical 
studies and widens the dose response curve of nicotine (Biswas et al., 2016; Wickham, 2019). 
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Cues are potent drivers of relapse to drugs, and menthol can act as a cue as well as 
enhance the rewarding value of other nicotine paired cues (Wickham, 2019). Study 2 aimed to 
examine if menthol increases nicotine's effect on the salience of environmental cues in human 
smokers. More specifically, it was hypothesized that menthol smokers would have stronger urges 
to smoke associated with environmental cues, menthol smokers would have a more difficult time 
quitting than nonmenthol smokers, and that menthol smokers would be more likely to use a 
smoking cessation tool than nonmenthol smokers.  
Study 1 
Methods 
Subjects 
Twenty male Sprague-Dawley rats (250-300g) from Charles River Laboratories were 
housed 2 to 3 per cage and provided ad libitum food and water on a 12-hour light/dark cycle 
beginning at 7 am. Four subjects were removed from analysis due to unreliable data recordings 
and an additional subject was removed from analysis due to insufficient data collection. All 
experiments were conducted according to the Guide for the Care and Use of Laboratory Animals 
and were approved by the Yale University Institutional Animal Care and Use Committee. 
Surgery 
Four small holes were drilled into the skulls of anesthetized rats for the insertion of a 
bipolar stimulator retrofitted with a cannula, a carbon microfiber electrode, a reference wire, and 
a screw to secure the reference electrode. Anteroposterior (AP), mediolateral (ML), and 
dorsoventral (DV) coordinates were referenced from bregma. A bipolar, stainless steel 
stimulating electrode was inserted into the VTA (AP −5.2 mm, ML 0.5-1.5 mm, DV from 7.4 to 
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8.1 mm below dura). An Ag/AgCl reference electrode was inserted into the contralateral cortex 
and was held with a screw attached to the skull to minimize the number of manipulators used. 
The pia matter was punctured and removed, and a carbon-fiber microelectrode was implanted 
vertically in the NAc core (AP +1.2 mm, ML −1.4 mm, DV from 6.2 to 6.9 mm) (see Figure 2). 
Figure 2 
Placement of Stimulating and Recording Electrodes in Rat Brains 
 
Note. The stimulating electrode (black) was placed in the VTA to stimulate the release of DA in 
anesthetized rats and the recording electrode (white) was placed in the NAc to record DA release 
(Kauer & Malenka, 2007). 
Fast-Scan Cyclic Voltammetry (FSCV)  
Electrical stimulation (300µA, 60Hz, 24 pulses) was applied to the VTA using a bipolar 
electrode to evoke phasic DA release in the NAc core of the anesthetized subjects. Each 
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stimulation was applied every 3 minutes so DA releasable stores could return to their original 
levels. 
FSCV is a method of examining neurotransmitter signaling within the brain that provides 
high chemical selectivity and temporal resolution (Wickham et al., 2014). During FSCV current 
is generated at different potentials and the redox reactions for different neurotransmitters are 
recorded and displayed with distinct peaks for oxidation and reduction (Wickham et al., 2014). 
Dopamine is absorbed onto the FSCV carbon microfiber electrode and the electrode records the 
oxidation of DA into DA-orthoquinone and the subsequent reduction of DA-orthoquinone into 
DA (see Figure 3). 
Figure 3 
The Methodology of Fast-Scan Cyclic Voltammetry  
 
 Note. DA is absorbed onto the carbon fiber microelectrode, at 0.6V DA is oxidized into DA-
orthoquinone and at -0.2V reduced back into DA, voltage is cycled every 100ms (Foster, 2014). 
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Experimental Design and Data Analysis 
 Six baseline recordings of DA release were recorded from each subject. Intraperitoneal 
(IP) injections of nicotine (n = 8, 0.35mg/kg in 0.09% saline) or menthol (n = 7, 400mg/kg in 5% 
DMSO, 45% Tween, and 50% vehicle) were then administered and DA measurements continued 
for 30 minutes. In five rats that received IP nicotine injections, IP menthol injections were 
administered 30 minutes later, and DA measurements were collected for an additional 30 
minutes. 
 All FSCV recordings were converted to percent baseline for analysis. A one-way 
Analysis of Variance (ANOVA) was conducted to analyze the effect of time on each drug 
condition. A two-way within subjects ANOVA was conducted to analyze the effects of menthol 
when nicotine was already in the system, and a two-way mixed-model ANOVA was conducted 
to analyze the effects of nicotine versus menthol over time. 
Results 
A one-way ANOVA revealed that there was a significant effect of time on nicotine 
exposure alone, F(15, 105) = 2.056, p = 0.018. Bonferroni’s post-hoc test showed significance 
from baseline to six minutes post-injection, p = 0.0034 (see Figure 4). A one-way ANOVA 
revealed that there was no significant effect of time on menthol exposure alone F(15, 90) = 
1.581, p = 0.095 or nicotine and menthol exposure combined F(12, 48) = 1.270, p = 0.267.  
 A two-way within subjects ANOVA on nicotine and menthol in combination revealed 
that there was no significant effect of time F(12, 48) = 0.547, p = 0.872, drug F(1, 4) = 0.611, p 
= 0.478, or time x drug F(12, 48) = 1.304, p = 0.248. A two-way between subjects ANOVA on 
nicotine alone and menthol alone revealed that there was no significant effect of time F(15, 195) 
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= 1.061, p = 0.396, however, there was a significant effect of drug F(1, 13) = 5.946, p  = 0.030, 
and there was a significant effect of time x drug F(15, 195) = 2.544, p = 0.002. 
Figure 4 
Effects of Nicotine and Menthol Exposure on Phasic Dopamine Release in the Nucleus 
Accumbens 
 
Note. Baseline recordings were taken before the administration of each drug condition: nicotine 
(n = 8), menthol (n = 7), and nicotine and menthol (n = 5). DA levels were recorded for 30 
minutes post drug exposure. After 30 minutes, menthol was administered to a subset of 5 
subjects from the nicotine condition and the subsequent DA levels were recorded for an 
additional 30 minutes and were compared to the last 3 DA recordings in the nicotine condition to 
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examine any additive effects of menthol when nicotine is already present in the system. Data are 
presented as the mean ± SEM. * = p < 0.05 
Discussion 
 Study 1 explored whether acute menthol exposure could influence phasic DA release in 
the NAc. The results of this study confirm that nicotine enhances phasic DA release in the NAc, 
however, menthol alone does not increase DA release, nor does menthol have any additive 
effects on DA release in conjunction with nicotine.  
 In the current literature, systemic changes in nAChR expression are found after exposure 
to chronic menthol (Henderson et al., 2016; Henderson et al., 2017; Ton et al., 2015). While the 
results did not indicate significant changes in DA levels in this study, this could be because acute 
menthol exposure was utilized rather than chronic menthol exposure. It is possible that acute 
menthol has no significant systemic reactions, but rather is more important for the acquisition of 
nicotine consumption because of its ability to mask the aversive taste of nicotine and to coat the 
lungs so smoke inhalation is more tolerable (Wickham, 2019). 
 Nicotine is the primary psychoactive ingredient in tobacco cigarettes, it produces 
euphoric effects and is the driving force behind tobacco addiction (Wickham, 2015). Menthol 
alone has no euphoric effects but is able to facilitate tobacco addiction through enhancing the 
appeal of nicotine products and making them available to larger populations (Wickham, 2015). It 
is possible that acute menthol exposure does not affect the rewarding properties of nicotine and 
tobacco consumption and acute menthol exposure is instead more important for the initial 
acquisition of smoking behavior. 
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These data speak to acute effects of menthol and nicotine, not chronic effects of menthol 
where many nAChR effects are observed. Keeping this in mind, one major limitation to Study 1 
is the small sample size, most notably that only five rats received nicotine and then menthol to 
examine potential additive effects.  Future studies should examine menthol’s influence on DA 
release in the NAc using at least ten rats per experimental condition and more conditions should 
be examined to gain a better understanding for how menthol interacts with DA release alone and 
in combination with nicotine. These conditions should include acute menthol exposure, acute 
nicotine exposure, acute menthol exposure after acute nicotine exposure to examine any additive 
effects, acute menthol and nicotine exposure simultaneously to examine combined effects, as 
well as chronic effects of menthol and nicotine exposure with each condition. 
These results imply that the role of menthol in nicotine and tobacco addiction is more 
complex than simply increasing DA release, leading to a greater feeling of pleasure. Nicotine 
produces rewarding behaviors through increased DA release, which implies that nicotine is the 
driving force behind tobacco addiction. The role of menthol in tobacco addiction appears to be 
more complex and requires further research to be fully understood. 
Study 2 
 Study 2 compared smoking behavior and motivations between menthol and nonmenthol 
preferring smokers. It was hypothesized that menthol smokers would have stronger urges to 
smoke associated with environmental cues, more difficulty quitting, and be more likely to use a 
smoking cessation tool than nonmenthol preferring smokers. 
Methods 
Participants 
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One hundred participants, 42 menthol smokers and 58 nonmenthol smokers, completed a 
five-minute online survey about their smoking preference and behavior. Data from three 
respondents were removed from analysis because when asked “at what age did you begin using 
nicotine products” they responded with “never.” Of the 100 respondents that were included in 
analysis, 22 were 18-24, 15 were 25-39, 46 were 40-59, and 17 were 60+; 93 were White, 3 were 
Black/African American, 1 was Latino/Hispanic, and 3 classified themselves as “other”; 75 were 
female, 22 were male, and 3 were nonbinary; 2 had less than a high school degree, 20 had a high 
school degree or equivalent, 5 had a trade school degree, 26 had some college but no degree, 9 
had an Associate Degree, 23 had a Bachelor’s Degree, 13 had a Master’s Degree, and 2 had a 
PhD or higher; 10 lived in an urban area, 31 lived in a suburban area, and 59 lived in a rural area; 
58 grew up in a smoking household and 42 grew up in a nonsmoking household; and 7 believed 
menthol cigarettes are less dangerous than nonmenthol cigarettes.  
Participants were recruited from different social media platforms utilizing the snowball 
effect method. One initial request was sent out, to take the survey if eligible or to share the 
survey link, and participants were recruited through subsequent reposts of the initial request. 
This study was approved by the Elizabethtown College Institutional Review Board in February 
2021.  
Design 
Participants were asked to respond to yes/no, fill in the blank, and multiple-choice 
questions to understand each individual’s background and smoking preference. These questions 
included “have you smoked in the last 30 days?” (yes/no), “I prefer to smoke 
___________(menthol/nonmenthol) cigarettes”, “Have you ever smoked mentholated 
cigarettes?” (yes/no), “do you currently smoke tobacco on a daily basis, less than daily, or not at 
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all?”, “have you smoked tobacco daily in the past?” (yes/no), “in the past, have you smoked 
tobacco on a daily basis, less than daily, or not at all?”, “have you ever wanted to quit smoking?” 
(yes/no), “have you ever attempted to quit smoking?” (yes/no), “have you ever successfully quit 
smoking?” (yes/no), “how many times have you attempted to quit smoking?” (1-6+), “how many 
times have you begun smoking again after attempting to quit?” (1-6+), “have you ever used a 
smoking cessation tool (i.e. Chantix [Varenicline] or Zyban [Bupropion]) or nicotine 
replacement therapy (i.e. nicotine patch, gum, spray, lozenge, inhaler, etc.)?” (smoking cessation 
tool, nicotine replacement therapy, both, neither), and “during the past 12 months, have you tried 
to stop smoking?” (yes/no). 
Participants were then asked to respond to statements using a five-point Likert scale, 
where 1 indicated strongly disagree, 2 indicated disagree, 3 indicated neutral, 4 indicated agree, 
and 5 indicated strongly agree, in order to understand how environmental cues may impact the 
smoking behaviors of each individual. Likert scale statements included: “when I am in a specific 
environment, I feel a stronger urge to smoke”, “I feel the urge to smoke in inappropriate places”, 
“I often feel the urge to smoke when I see a cigarette”, “I smoke to feel better”, “I smoke to feel 
good”, “I smoke because I am bored”, “I smoke to relieve cravings”, “I smoke to relieve 
withdrawal symptoms”, “I often feel the urge to smoke when I see an ashtray”, “I smoke without 
thinking about it”, “Smoking feels like a habit”, “I often feel the urge to smoke when I see a 
lighter”, and “I often smoke in the same location”; some of these questions were taken from a 
scale used by Newton and colleagues (2009) to examine theories of addiction (Cronbach’s α = 
898).  
Demographics collected included current age, the age participants began using nicotine 
products, race, gender, education level, community type, if the participant grew up in a smoking 
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or nonsmoking household, and if the participant believes menthol cigarettes are less dangerous 
than nonmentholated cigarettes. 
 An independent samples t-test was run to examine the relationship between menthol 
status and environmental cues and to examine the relationship between menthol status and age of 
acquisition, and chi-square test of association tests were run to examine the relationships 
between menthol status and the frequency of nicotine consumption, successful quit rate, 
utilization of smoking cessation tools, and demographics. 
Results 
An exploratory factor analysis revealed three main categories when examining the 
relationship between menthol status and the reasons behind smoking behavior: emotion, urges, 
and environment (see Table 1). An independent samples t-test revealed no significant difference 
in emotion driving smoking behavior between menthol (M = 3.17, SD = 1.02) and nonmenthol 
smokers (M = 2.94, SD = 1.24), t(98) = 0.994, p = 0.323, d = 0.201; no significant difference in 
urges driving smoking behavior between menthol (M = 2.83, SD = 1.19) and nonmenthol 
smokers (M = 3.05, SD = 1.33), t(98) = -0.868, p = 0.388, d = -0.176; and no significant 
difference in environment driving smoking behavior between menthol (M = 1.68, SD = 0.999) 
and nonmenthol smokers (M = 1.94, SD = 1.11), t(98) = -1.21, p = 0.230, d = -0.245 (see Figure 
5). An independent samples t-test revealed no difference age of acquisition between menthol (M 
= 16.6, SD = 3.72) and nonmenthol smokers (M = 16.6, SD = 5.48), t(97) = -0.0307, p = 0.976, d 
= -0.00625 (see Figure 6). 
Table 1 
Exploratory Factor Analysis of the Variables Related to Smoking Behavior 
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Factor Loadings 
 Factor  
  1 2 3 Uniqueness 
When I am in a specific environment, I feel a stronger urge to 
smoke. 
 0.568        0.6148  
I feel the urge to smoke in inappropriate places.           0.6869  
I often feel the urge to smoke when I see a cigarette.           0.4799  
I smoke to feel better.  0.718        0.3612  
I smoke to feel good.  0.895        0.2198  
I smoke because I am bored.  0.616        0.3841  
I smoke to relieve cravings.     0.607     0.4166  
I smoke to relieve withdrawal symptoms.     0.619     0.4801  
I often feel the urge to smoke when I see an ashtray.        0.719  0.3448  
I smoke without thinking about it.     0.778     0.4323  
Smoking feels like a habit.     0.641     0.4219  
I often feel the urge to smoke when I see a lighter.        0.971  0.0479  
I often smoke in the same location.           0.5945  
 
Note. 'Minimum residual' extraction method was used in combination with an 'oblimin' rotation. 
Factor loadings below 0.5 were excluded from analysis. Factor 1 indicates variables in the 
Emotion category, Factor 2 indicates variables in the Urges category, and Factor 3 indicates 
variables in the Environment category. 
Figure 5 
Independent Samples T-Test Examining the Motivation Behind Smoking Behavior 
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Note. Higher numbers are indicative of stronger motivations to smoke. Data is displayed as mean 
± SEM. 
Figure 6 
The Relationship of Menthol Status with Age of Acquisition  
 
Note. Data is displayed at mean ± SEM. 
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 Chi-square test of association were run to examine the relationship between menthol 
status and smoking behavior. There was no relationship between menthol status and desire to 
quit smoking, χ2 (1, N = 100) = 0.072, p = 0.788, Cramer’s V = 0.027 (see Figure 7). There was 
no relationship between menthol status and successful quit rate, χ2 (1, N = 100) = 0.493, p = 
0.483, Cramer’s V = 0.070 (see Figure 8). There was no relationship between menthol status and 
number of attempts to quit smoking, χ2 (6, N = 100) = 4.15, p = 0.656, Cramer’s V = 0.204 (see 
Figure 9a), or number of times relapsing after attempting to quit, χ2 (6, N = 100) = 2.43, p = 
0.877, Cramer’s V = 0.156 (see Figure 9b). There was no relationship between menthol status 
and utilization of a smoking cessation tool, χ2 (3, N = 100) = 1.50, p = 0.682, Cramer’s V = 
0.123 (see Figure 10). There was no relationship between menthol status and smoking daily, χ2 
(1, N = 100), p = 0.116, Cramer’s V = 0.157 (see Figure 11). There was no relationship between 
menthol status and if participants believed menthol cigarettes are less dangerous than 
nonmentholated cigarettes, χ2 (1, N = 100) = 0.00227, p = 0.962, Cramer’s V = 0.00476 (see 
Figure 12). 
Figure 7 
Menthol Status Differences in Desire to Quit Smoking 
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Note. Data is displayed as the mean of each group. 
Figure 8 
Menthol Status Differences in Successful Smoking Cessation 
 
Note. Data is displayed as the mean of each group. 
Figure 9 
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Menthol Status Differences in Number of Attempts to Quit 
  
Note. Figure 9a: Data is displayed as the mean of each group. 
Menthol Status Differences in Number of Relapses 
 
Note. Figure 9b: Data is displayed as the mean of each group. 
Figure 10 
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Menthol Status Differences in Use of a Smoking Cessation Tool 
 
Note. Data is displayed as the mean of each group. 
Figure 11 
Menthol Status Differences in Smoking Daily 
 
Note. Data is displayed as the mean of each group. 
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Figure 12 
Menthol Status Differences in Opinion on if Menthol Cigarettes are Less Dangerous than 
Nonmenthol Cigarettes 
 
Note. Data is displayed as the mean of each group. 
 Chi-square test of association were also run to compare menthol status within each 
demographic collected. There was no relationship between menthol status and growing up in a 
smoking or nonsmoking household, χ2 (1, N = 100) = 1.90, p = 0.168, Cramer’s V = 0.138 (see 
Figure 13). There was no relationship between menthol status and type of area participants lived 
in, χ2 (2, N = 100) = 0.610, p = 0.737, Cramer’s V = 0.078 (see Figure 14). There was no 
relationship between menthol status and the highest level of education participants had 
completed, χ2 (7, N = 100) = 13.9, p = 0.054, Cramer’s V = 0.372 (see Figure 15). There was no 
relationship between menthol status and gender, χ2 (2, N = 100) = 2.72, p = 0.256, Cramer’s V = 
0.165 (see Figure 16). There was no relationship between menthol status and race, χ2 (5, N = 
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100) = 5.01, p = 0.415, Cramer’s V = 0.224 (see Figure 17). There was a relationship between 
menthol status and age, χ2 (3, N = 100) = 21.7, p < .001, Cramer’s V = 0.466 (see Figure 18). 
Figure 13 
Menthol Status Differences in Household Environment Growing Up 
 
Note. Data is displayed as the mean of each group. 
Figure 14 
Menthol Status Differences in Participant Living Location 
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Note. Data is displayed as the mean of each group. 
Figure 15 
Menthol Status Differences in Level of Education 
 
Note. Data is displayed as the mean of each group. 
Figure 16 
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Menthol Status Differences in Gender 
 
Note. Data is displayed as the mean of each group. 
Figure 17 
Menthol Status Differences in Race 
 
Note. Data is displayed as the mean of each group. 
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Figure 18 
Menthol Status Differences in Age 
 
Note. There were significantly more nonmenthol smokers aged 40-59 than menthol smokers. 
Data is displayed as the mean of each group. * = p < .001 
Discussion 
 While the results from Study 2 do not support the hypothesis that menthol smokers would 
have stronger associations with environmental cues and would have a more difficult time with 
smoking cessation, these results do have interesting implications. Abstinence outcomes are 
independent of menthol status which implies that menthol status does not affect the rate of 
successful smoking cessation, although a recent meta-analysis from Smith and colleagues (2020) 
indicates this may only be in Black populations (Jao et al., 2017). Pre-existing differences, 
including biological differences, between menthol preferring and non-preferring smokers may 
influence their perception of nicotine as well as their response to short term abstinence programs 
(DeVito et al., 2016). This suggests that individual differences contribute more to successful 
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smoking cessation than menthol status itself, and furthermore implies that there may be 
biological reasons behind why an individual prefers mentholated cigarettes to nonmentholated 
cigarettes and it may be those reasons, not the menthol itself, that leads to less success with 
smoking cessation that is seen in established literature (DeVito et al., 2016; Fait et al., 2017; 
Henderson et al., 2017; Wickham, 2019). It is possible that future research on this could lead to 
enhancements in smoking cessation interventions. 
 Results did indicate that individuals who are 40-59 years old are more likely to smoke 
nonmenthol cigarettes than menthol cigarettes. This makes sense within the current literature 
because menthol cigarettes are marketed toward younger populations (Lee & Glantz, 2011). 
Nicotine is reinforcing on its own. Menthol may not necessarily increase how reinforcing 
nicotine is, but it can blunt the positive responses to nicotine and is correlated with less severe 
nicotine withdrawal after overnight nicotine deprivation (Valentine et al., 2018). Lifetime 
smokers exhibit no acute effects of menthol, which indicates that menthols’ effects appear to be 
more long term in which the plasticity of the brain is altered via changes in nAChRs (Valentine 
et al., 2018; Wickham, 2019). It is possible that there is a ceiling effect wherein the effects of 
nicotine are so potent that menthol does not have the ability to create additive effects in 
established smokers, similar to how there is a decline in cue reactivity of established smokers 
due to a ceiling effect (Karelitz, 2020). 
Keeping this in mind, it is important to address the limitations of this study. There are 
limitations in the design of the online study. Most questions were not taken from a questionnaire 
that has a known reliability, instead they were made by the author. Questions that target more 
specific behavior of menthol versus nonmenthol preferring smokers could have been asked and 
participants could have been directed to more specific questions depending on their responses to 
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questions about their menthol status. Specifics should have been asked about environmental cues 
as well, for example after each Likert scale question was answered there could have been a 
follow up question asking participants to explain their responses, for example what specifically 
makes them feel a stronger urge to smoke. The questions that were ultimately asked were general 
in nature and it would have been interesting to see if there were any commonalities between 
menthol status if participants were asked to elaborate for themselves. 
 Future studies should examine smoking behavior throughout the duration of an 
individual’s time smoking cigarettes. Questions should examine motivation behind beginning to 
smoke, current smoking behaviors, attitudes toward menthol and nicotine in general, and 
intentions toward smoking cessation. I would also be interesting to conduct personal interviews 
with participants to gather more information from participants in an open-ended manner. It is 
possible that environmental cues related to smoking behavior may operate nonconsciously which 
would mean participants could not report their reactions to these cues themselves. Instead, a 
behavioral measure could be used to examine if this is the case. For a follow-up like this, 
menthol and nonmenthol smokers would both experience the same cue, for example watching a 
video of someone lighting a cigarette, and each participant would be asked to rate their craving 
for a cigarette before and after the cue is administered. Overall, it is important to note that while 
there was no difference in menthol status on efficacy of environmental cues or smoking 
cessation, there could be underlying differences in menthol status that were not addressed with 
this survey. 
Conclusion 
The results of Study 1 confirm that nicotine elevates phasic dopamine release in the 
mesolimbic pathway, which aligns with the first hypothesis of the study. The second hypothesis, 
37 
 
that menthol alone would have no significant effect on dopamine release, was also supported by 
data from Study 1. The third hypothesis, that the addition of menthol would have an additive 
effect on dopamine release elicited by nicotine, was not supported. Menthol had no additive 
effect on dopamine release when nicotine was already present in the system. This is likely due to 
the use of acute menthol exposure for Study 1, or due to the delay in administration of menthol 
after nicotine. It is possible that there are effects that are dependent on when nicotine and 
menthol are administered in relation to each other. 
Results of Study 2 did not support the hypothesis that menthol smokers would have 
stronger urges to smoke associated with environmental cues, a more difficult time quitting, and 
be more likely to use a smoking cessation tool than nonmenthol smokers. The present results 
indicate that there is no difference in menthol status on the salience of environmental cues acting 
as motivation behind smoking behavior.  
 Taken together the results of Study 1 and Study 2 have interesting implications. Nicotine 
is the addictive substance in tobacco cigarettes, not menthol, however, menthol can help 
facilitate the acquisition of smoking because it makes the consumption of nicotine less aversive 
by providing relief from smoke inhalation and masking the aversive taste associated with 
nicotine (Wickham, 2019). The mechanisms behind the interaction between menthol and 
nicotine are more complex than initially believed and future research should examine menthol 
independently from nicotine, as well as combined, in several different conditions to examine 
how DA release and nAChR expression are affected. Results from these preclinical studies can 
be applied in human research to better understand how menthol status can affect nicotine 
acquisition, continued use, and smoking cessation. The use of more specific survey questions 
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geared toward understanding the motivations behind smoking behavior may yield a deeper 
understanding of menthol’s role in the acquisition and continuations of nicotine use. 
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